Some 80-90% of gastrinomas are located in the gastrinoma triangle, which includes the duodenum, the pancreatic head, and the hepatoduodenal ligament. The natural history of the tumors depends on their origin. Duodenal gastrinomas are much less aggressive than pancreatic primaries and infrequently develop liver metastases. The reason therefore is unclear. The transcription factor pancreatic-duodenal homeobox 1 (Pdx1) is important in differentiation and development of the pancreas and duodenum. In embryonic development, Sonic hedgehog (Shh) expression establishes a sharp molecular boundary, which allows for the proper patterning of the duodenal and pancreatic epithelium. Pancreatic polypeptide (PP) is expressed in pancreatic islets and is known to be expressed in pancreatic endocrine tumors. This study aims to clarify the expression pattern of Pdx1, Shh, and PP in duodenal and pancreatic gastrinomas. Tissue from 15 patients with duodenal and from 11 patients with pancreatic gastrinomas that underwent surgery between 1987 and 2007 at our institution because of a gastrinoma were evaluated by immunohistochemistry (IHC). Furthermore, tissue from lymph node metastases from two patients with a so far undetected primary gastrinoma was analyzed. IHC revealed strong Pdx1 expression in pancreatic gastrinomas, but not in duodenal gastrinomas. By contrast, there was no Shh expression detectable in pancreatic gastrinomas, but found in all duodenal gastrinomas. This pattern was also true for associated metastases. Shh expression combined with absence of Pdx1 expression in lymph node metastases from patients with an unknown location of the primary suggests a so far undetected duodenal gastrinoma. We show for the first time that only pancreatic, but not duodenal gastrinomas express Pdx1. Moreover, only duodenal gastrinomas express Shh, suggesting a different genetic background of these two tumors. Whereas the expression of Pdx1 in pancreatic gastrinomas might suggest their endocrine origin from islets, duodenal gastrinomas develop from a Pdx1 negative cell cluster. The expression pattern of Pdx1, Shh, and PP in resected metastases can help to locate an otherwise undetected primary gastrinoma.

Download full-text PDF

Source
http://dx.doi.org/10.1677/ERC-08-0204DOI Listing

Publication Analysis

Top Keywords

pancreatic gastrinomas
24
duodenal gastrinomas
24
pancreatic
13
gastrinomas
13
duodenal pancreatic
12
shh expression
12
duodenal
11
expression
9
sonic hedgehog
8
pancreatic-duodenal homeobox
8

Similar Publications

Article Synopsis
  • Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) can be either hormone-secreting or non-secreting, have serious health implications, and an average survival of 75-124 months.
  • Research shows that key genes involved in the tumor's development, especially epigenetic regulators like MEN1, DAXX, and ATRX, are often mutated, but their effects are not well understood.
  • The calcium sensing receptor (CaSR) is significantly reduced in GEP-NETs, potentially due to DNA methylation and chromatin modifications, suggesting it functions as a tumor suppressor by inhibiting cell growth in pancreatic NETs.
View Article and Find Full Text PDF

Cadherin 17 (CDH17) and claudin 18.2 (CLDN18.2) are highly selective markers of intestinal and gastric lineages and are expressed in adenocarcinomas of various organs.

View Article and Find Full Text PDF

Unlabelled: Pancreatic masses are extremely rare in pediatric patients, with limited data available. This lack of data makes the diagnosis and management of these tumors in children extremely challenging. Therefore, we aimed to describe the presentations, clinical course, and outcomes of children with pancreatic tumors at our center.

View Article and Find Full Text PDF

Characteristics, therapy, and outcome of rare functioning pancreatic neuroendocrine neoplasms.

Sci Rep

August 2024

Department of Visceral, Thoracic and Vascular Surgery, University Hospital Marburg, Philipps University Marburg, Marburg, Germany.

Article Synopsis
  • * Out of 216 patients with pNENs treated from 2002 to 2022, 12 were identified as rf-pNENs, including different subtypes like vasoactive intestinal polypeptide, glucagon, and calcitonin-producing tumours.
  • * Following surgery, most patients showed positive outcomes, with a median follow-up of 75 months indicating that those who had complete resections (R0) and no liver metastases had a better prognosis, with six patients remaining alive and disease-free.
View Article and Find Full Text PDF

A cross-species transcriptomic analysis reveals a novel 2-dimensional classification system explaining the invasiveness heterogeneity of pancreatic neuroendocrine tumor.

Cancer Lett

July 2024

Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100730, China; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100730, China. Electronic address:

Article Synopsis
  • Pancreatic neuroendocrine tumors (PanNETs) show a wide range of invasiveness, and existing genomic knowledge sheds some light on this variability, especially between different types like insulinomas and other PanNET variants.
  • Researchers used a 2D classification system based on RNA sequencing of PanNETs from both mouse models and humans to categorize these tumors primarily into benign insulinomas and various invasive subtypes.
  • By integrating the 2D classification, specific mutation status (DAXX/ATRX), and tumor size, they identified a subset of PanNETs with low recurrence risk, helping to clarify the complexity of these tumors and enhance their prognostic evaluation.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!